Targeted Exon Sequencing in Usher Syndrome Type I
Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Eric A. Pierce(Broad Institute), Eliot L. Berson(Massachusetts Eye and Ear Infirmary), Xiaowu Gai(Massachusetts Eye and Ear Infirmary), Daniel Navarro-Gomez, Mark Consugar(Massachusetts Eye and Ear Infirmary), Daniel G. Taub(Boston University), Joseph White(Florida International University), Scott Q. Harper(Nationwide Children's Hospital), Michael H. Farkas(Buffalo State University), Emily Place(MACOM (United States)), Jean‐Paul Léna(Lyon 1 Université), Carol Weigel DiFranco(Massachusetts Eye and Ear Infirmary)
Cited by 28
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k